Interleukin-6 (IL-6) and its soluble receptor support survival of sensory neurons

Journal of Neuroscience Research

Volumn 55, Issue 4, 1999, Pages 411-422

  Thier, M ^a   Marz P ^b   Otten, U ^c   Weis, J ^d   Rose John, S ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Dorsal root ganglion; Neuropoietic cytokine; Neurotrophic; Soluble receptor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; METALLOPROTEINASE; NERVE GROWTH FACTOR; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; GROWTH REGULATION; IMMUNOHISTOCHEMISTRY; NERVE CELL DEGENERATION; NERVE FIBER REGENERATION; NERVE FIBER TRANSECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SPINAL GANGLION;

ANIMALS; ANIMALS, NEWBORN; AUTOCRINE COMMUNICATION; CELL DEATH; CELLS, CULTURED; CILIARY NEUROTROPHIC FACTOR; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SPINAL; HUMANS; INTERLEUKIN-6; NERVE GROWTH FACTOR; NEURONS, AFFERENT; RATS; RECEPTORS, INTERLEUKIN-6;

EID: 0345004849     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990215)55:4<411::AID-JNR2>3.0.CO;2-D     Document Type: Article

References (52)

1. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM. 1987. Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411-1416.
2. Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, Squinto SP, Yancopoulos GD, Lindsay RM. 1995. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374:450-453.
3. Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson A, Lindsay RM, Wiegand SL. 1997. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389:856-860.
4. Balasingam V, Tejada Berges T, Wright E, Bouckova R, Yong VW. 1994. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 14:846-856.
5. Barde YA. 1989. Trophic factors and neuronal survival. Neuron 2:1525-1534.
6. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, Mucke L. 1993. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 90:10061 -10065.
7. Economides AN, Ravetch JV, Yancopoulos GD, Stahl N. 1995. Designer cytokines: targeting actions to cells of choice. Science 270:1351-1353.
8. Ehlers M, de Hon FD, Bos HK, Horsten U, Kurapkat G, van De Leur HS, Grötzinger J, Wollmer A, Brakenhoff JP, Rose-John S. 1995. Combining two mutations of human interleukin-6 that affect gp130 activation results in a potent interleukin-6 receptor antagonist on human myeloma cells. J Biol Chem 270:8158-8163.
9. Fann MJ, Patterson PH. 1994. Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured sympathetic neurons. Proc Natl Acad Sci USA 91:43-47.
10. Fattori E, Lazzaro D, Musiani P, Modesti A, Alonzi T, Ciliberto G. 1995. IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur J Neurosci 7:2441-2449.
11. Fischer M, Goldschmitt J, Peschel C, Kallen KJ, Brakenhoff JPJ, Wollmer A, Grötzinger J, Rose-John S. 1997. A designer cytokine with with activity on human hematopoietic progenitor cells. Nat Biotech 15:142-145.
12. Gadient RA, Otten U. 1994. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res 637:10-14.
13. Gadient RA, Otten U. 1996. Postnatal expression of interleukin-6 (IL-6) and IL-6 receptor (IL-6R) mRNAs in rat sympathetic and sensory ganglia. Brain Res 724:41-46.
14. Hama T, Miyamoto M, Tsukui H, Nishio C, Hatanaka H. 1989. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci Lett 104:340-344.
15. Hampel H, Sunderland T, Kotter HU, Schneider C, Teipel SJ, Padberg F, Dukoff R, Levy J, Moller HJ. 1998. Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease. Brain Res 780:356-359.
16. Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB. 1993. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Transplantation 55:1112-1118.
17. Hirota H, Kiyama H, Kishimoto T, Taga T. 1996. Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J Exp Med 183:2627-2634.
18. Honda M, Yamamoto S, Cheng M, Yasukawa K, Suzuki H, Saito T, Osugi Y, Tokunaga T, Kishimoto T. 1992. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 148:2175-2180.
19. Hopkins SJ, Rothwell NJ. 1995. Cytokines and the nervous system I: expression and recognition. Trends Neurosci 18:83-88.
20. Horton AR, Davies AM, Buj-Bello A, Bertlett P, Murphy M. 1996. Leukemia inhibitory factor and ciliary neurotrophic factor in sensory neuron development. Persp Dev Neurobiol 4:35-38.
21. Ikeda K, Kinoshita M, Tagaya N, Shiojima T, Taga T, Yasukawa K, Suzuki H, Okano A. 1996. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease. Brain Res 726:91-97.
22. Koliatsos VE, Price DL. 1996. Axotomy as an experimental model of neuronal injury and cell death. Brain Pathol 6:4474-4465.
23. Kurek JB, Austin L, Cheema SS, Bartlett PF, Murphy M. 1996. Up-regulation of leukaemia inhibitory factor and interleukin-6 in transected sciatic nerve and muscle following denervation. Neuromuscul Disord 6:105-114.
24. Kushima Y, Hatanaka H. 1992. Culture of neuronal cells from postnatal rat brain: application to the study of neurotrophic factors. Prog Neuropsychopharmacol Biol Psychiatry 16:617-633.
25. Lindsay RM. 1996. Therapeutic potential of the neurotrophins and neurotrophin-CNTF combinations in peripheral neuropathies and and motor neuron diseases. In: Ciba Found Symp 196: Growth factors as drugs for neurological and sensory disorders. Chichester: Wiley. p 39-53.
26. Mackiewicz A, Schooltink H, Heinrich PC, Rose-John S. 1992. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J Immunol 149:2021-2027.
27. März P, Cheng J-G, Gadient RA, Patterson PH, Stoyan T, Otten U, Rose-John S. 1998. Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci USA 95:3251-3256.
28. Miller RG, Petajan JH, Bryan WW, Armon C, Barohn RJ, Goodpasture JC, Hoagland RJ, Parry GJ, Ross MA, Stromatt SS, rhCNTF ALS Study Group. 1996. A placebo-controlled trial of recombinant human ciliary neurotrophic factor (rhCNTF) in amyotrophic lateral sclerosis. Ann Neurol 39:256-260.
29. Müllberg J, Schooltink H, Stoyan T, Günther M, Graeve L, Buse G, Mackiewicz A, Heinrich PC, Rose-John S. 1993. The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 23:473-180.
30. Murphy M, Reid K, Brown MA, Bartlett PF. 1993. Involvement of leukemia inhibitory factor and nerve growth factor in the development of dorsal root ganglion neurons. Development 117:1173-1182.
31. Murphy PG, Grondin J, Altares M, Richardson PM. 1995. Induction of interleukin-6 in axotomized sensory neurons. J Neurosci 15: 5130-5138.
32. Oh YJ, O'Malley KL 1994. IL-6 increases choline acetyltransferase but not neuropeptide transcripts in sympathetic neurons. Neuroreport 5:937-940.
33. Panayotatos N, Radziejewska E, Acheson A, Somogyi R, Thadani A, Hendrickson WA, McDonald NQ. 1995. Localizition of functional receptor epitopes on the structure of ciliary neurotrophic factor indicates a conserved, function-related epitope topography among helical cytokines. J Biol Chem 270:14007-14014.
34. Papadaki H, Kyriakou D, Foudoulakis A, Markidou F, Alexandrakis M, Eliopoulos GD. 1997. Serum levels of soluble IL-6 receptor in multiple myeloma as indicator of disease activity. Acta Haematol 97:191-195.
35. Penn RD, Kroin JS, York MN, Cedarbaum JM. 1997. Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial). Neurosurgery 40:94-100.
36. Reichert F, Levitzky R, Rotshenker S. 1996. Interleukin 6 in intact and injured mouse peripheral nerves. Eur J Neurosci 8:530-535.
37. Rose-John S, Heinrich PC. 1994. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 300:281-290.
38. Rothwell NJ, Hopkins SJ. 1995. Cytokines and the nervous system II: actions and mechansims of action. Trends Neurosci 18:130-136.
39. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF. 1990. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol 144:129-135.
40. Sendtner, M, Carroll P, Holtmann B. Hughes RA, Thoenen H. 1994. Ciliary neurotrophic factor. J Neurobiol 25:1436-1453.
41. Sendtner M, Götz R, Holtmann B, Thoenen H. 1997. Endogenous ciliary neurotrophic factor is a lesion factor for axotomized motoneurons in adult mice. J Neurosci 17:6999-7006.
42. Silvani A, Ferrari G, Paonessa G, Toniatti C, Parmiani G, Colombo MP. 1995. Down-regulation of interleukin 6 receptor alpha chain in interleukin 6 transduced melanoma cells causes selective resistance to interleukin 6 but not to oncostatin M. Cancer Res 55:2200-2205.
43. Simon, R, Thier M, Krüttgen A, Rose-John S, Weiergräber O, Heinrich PC, Schroder JM, Weis J. 1995. Human CNTF and related cytokines: effects on DRG neurone survival. Neuroreport 7:153-157.
44. Snider WD. 1994. Functions of neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77:627-638.
45. Taga T, Kishimoto T. 1997. gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797-819.
46. Thibault V, Richards CD, Botelho F, Gauldie J. 1997. Antibodies to rat soluble IL-6 receptor stimulate B9 hybridoma cell proliferation. FEBS Lett 408:182-186.
47. Thibault V, Terlain B, Gauldie J. 1996. Characterization and biologic activities of recombinant rat soluble interleukin-6 receptor. J Interferon Cytokine Res 16:973-981.
48. Thier M, Simon R, Krüttgen A, Rose-John S, Heinrich PC, Schröder JM, Weis J. 1995. Site-directed mutagenesis of human CNTF: functional analysis of recombinant variants. J Neurosci Res 40:826-835.
49. van Dam M, Müllberg J, Schooltink H, Stoyan T, Brakenhoff JP, Graeve L, Heinrich PC, Rose-John S. 1993. Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding. J Biol Chem 268:15285-15290.
50. van Snick J. 1990. Interleukin-6: an overview. Annu Rev Immunol 8:253-279.
51. Vollmer P, Peters M, Ehlers M, Yagame H, Matsuba T, Kondo M, Yasukawa K, Büschenfelde KH, Rose-John S. 1996. Yeast expression of the cytokine receptor domain of the soluble interleukin-6 receptor. J Immunol Methods 199:47-54.
52. Weis J, Lie DC, Ragoß U, Züchner S, Schröder JM, Karpati G, Farruggella T, Stahl N, Yancopoulos GD, DiStefano PS. 1998. Increased expression of CNTF receptor in denervated human skeletal muscle. J Neuropathol Exp Neurol 57:850-857.